β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells (scientific article published on 25 May 2016)

Genes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression

Q28257152

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

Q28508467

Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin

Q33945068

Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes

Q34060092

Lipoprotein cholesterol and atherosclerosis

Q34567400

Cholesterol depletion induces transcriptional changes during skeletal muscle differentiation

Q35198692

mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.

Q35588934

ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter

Q35621089

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

Q35836597

HDL as a target in the treatment of atherosclerotic cardiovascular disease

Q36058450

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

Q36267668

Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease

Q36478244

Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease

Q36818632

Role of ATP-binding cassette transporters in brain lipid transport and neurological disease

Q36987318

Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells

Q37815941

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

Q38155194

Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.

Q38166085

High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm

Q38203096

ATP-binding cassette transporter A1: from metabolism to neurodegeneration

Q38213077

ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.

Q39837617

A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts

Q40308383

ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I.

Q40339567

Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.

Q42503747

Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction

Q43077644

Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.

Q43465871

T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice

Q44314934

ABCA1 expression in carotid atherosclerotic plaques.

Q45140725

Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis

Q46080947

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model.

Q46256906

Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo

Q46859453

Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes.

Q48823131

Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.

Q50479986

Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.

Q52148894

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

Q52947546

Cholesterol depletion by methyl-β-cyclodextrin enhances cell proliferation and increases the number of desmin-positive cells in myoblast cultures.

Q53149554

A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells

Q57353725

P921

main subject

endothelium

Q111140

P304

page(s)

185

P577

publication date

2016-05-25

P1433

published in

Frontiers in Physiology

Q2434141

P1476

title

β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells

P478

volume

Reverse relations

cites work (P2860)

Q92263460	Cholesterol restricts lymphotoxin β receptor-triggered NF-κB signaling
Q89994072	Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1
Q28071254	Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
Q64057136	In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C
Q37587802	Interactions between cyclodextrins and cellular components: Towards greener medical applications?
Q28067186	There Is No Simple Model of the Plasma Membrane Organization

P356	DOI	10.3389/FPHYS.2016.00185
P8608	Fatcat ID	release_y2h3baypongrha3lykxpqp2zma
P932	PMC publication ID	4879322
P698	PubMed publication ID	27252658